Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PLSH | ISIN: JE00BJJN4441 | Ticker-Symbol: 16A
Frankfurt
26.04.24
15:29 Uhr
6,350 Euro
-0,050
-0,78 %
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
CLARIVATE PLC Chart 1 Jahr
5-Tage-Chart
CLARIVATE PLC 5-Tage-Chart
RealtimeGeldBriefZeit
6,6006,70026.04.
GlobeNewswire (Europe)
1.999 Leser
Artikel bewerten:
(2)

Exor N.V.: Clarivate and Exor sign agreement

Clarivate and Exor Sign Agreement Under Which Suzanne Heywood Will Be Nominated to Stand for Election to the Company's Board of Directors

Exor becomes a long-term investor in Clarivate, endorsing the strategic direction set out by the Company's Management and Board, and announces it now has a 10.1% shareholding in the Company and can increase its participation up to 17.5%

London, U.K., and Amsterdam, the Netherlands, March 4, 2024 - Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence and Exor N.V. (AEX:EXO), the Netherlands-based diversified holding company, today announced that Suzanne Heywood will be nominated for election to the Clarivate Board of Directors at the Company's next Annual General Meeting of shareholders on May 7, 2024. Under the terms of the agreement, Exor, which now owns 10.1% of Clarivate, may increase its participation up to 17.5% of Clarivate's outstanding ordinary share capital.

Jonathan Gear, CEO, Clarivate said: "We welcome Exor's commitment to our strategy as a long-term investor. I'm encouraged by their vote of confidence that conveys faith in our abilities to deliver solutions that our customers trust to fuel the world's greatest breakthroughs."

Andy Snyder, Chairman of the Board, Clarivate, commented: "We look forward to Suzanne joining the Board. She will bring tremendous in-depth experience from multiple Board roles for large global corporations and her guidance will be invaluable as we continue to transform Clarivate into a world-leading intelligence provider."

Suzanne Heywood said, "We are delighted to be a shareholder of Clarivate, a global provider of data, analytics, technology and expert services to several sectors including healthcare. By bringing our experience of building great companies to the board level, we look forward to help Clarivate achieve ambitious goals and express its full potential."

Suzanne Heywood is the COO of Exor and the Chair of CNH Industrial N.V. and Iveco Group. She was born in Southampton, England and has a Science MA from Oxford University and PhD from Cambridge University that she gained after a childhood spent sailing around the world on a boat. Suzanne started her professional career in the UK Treasury. In 1997, she joined McKinsey & Company where she held increasingly senior positions including, as a Senior Partner, co-leading McKinsey's global service line on operating model change. Suzanne is also a Board member of The Economist and Louboutin.

# # #

About Clarivate

Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

About Exor

Exor N.V. (AEX: EXO), is a diversified holding company that is based in the Netherlands and listed on the AEX. For over a century, Exor has built great companies and made successful investments worldwide, applying a culture that combines entrepreneurial spirit and financial discipline. Its portfolio is principally made up of companies in which Exor is the largest shareholder including Ferrari, Stellantis, CNH Industrial and Philips. For more information, please visit www.exor.com

Media contacts

media@exor.com - ir@exor.com

newsroom@clarivate.com - investor.relations@clarivate.com


Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.